Medtech Startup Qure.ai Raises $65 Mn to Fund Product Development and Expansion

Qure.ai, a medical technology business, has allegedly raised $65 million (INR 543 crore) in a Series D fundraising round headed by Lightspeed Venture Partners and 360 ONE Asset Management.
Merck Global Health Innovation Fund and Kae Capital also participated in the round, with current investors Novo Holdings, Health Quad, and TeamFund.
According to Bloomberg, it intends to utilize the cash to expand in the United States and other regions, strengthen its GenAI foundation models, and fund acquisitions. With this money, it plans to focus on building AI-based products to help disease identification.
This comes a week after media reports indicated that the business is trying to raise $50-60 million in a fundraising round headed by Lightspeed.

Related: Ace Angel Investor Karna D Shinde Funds Navaux’s Cancer Detection Technology

Qure.ai, founded in 2016 by Prashant Warier, employs artificial intelligence to aid in medical imaging diagnosis. It essentially employs artificial intelligence to diagnose brain damage, chest illnesses, and other conditions.
The company claimed that their system can discover clinically relevant aberrant injuries from X-rays, CT scans, and MRIs in a fraction of the time that clinicians normally do.
The Mumbai-based startup is supported by major investors such as Fractal Analytics and Sequoia Capital.

Qure.AI’s cofounder and CEO, Prashant Warier, told Bloomberg that AI is assisting in the resolution of healthcare bottlenecks. The technology is increasingly being applied in fields such as drug development, hospital patient management, and surgical robotics.
The Indian medtech industry is undergoing a dramatic shift, driven by digital health acceptance, AI integration, and the rise of wearable technologies. AI is transforming medical diagnoses and treatment, with startups and huge corporations spending extensively in the field.
For example, last month, medtech firm SigTuple raised $4 million (more than INR 33.5 crore) in an expanded Series C fundraising round led by Sidbi Venture Capital to expand its product range and initiatives.
In the same month, online healthcare service provider Visit Health raised INR 250 crore (almost $29.8 million) from PB Fintech’s affiliate, Docprime Technologies, through a combination of capital infusion and secondary share acquisition.
Meanwhile, healthtech unicorn Innovaccer was in talks with Kaiser Permanente, a large US health and insurance company, to raise $200 million to $250 million in a mix of primary and secondary finance.